1. Discovery of novel antitumor sulfonamides targeting GI phase of the cell cycle;Owa;J Med Chem,1999
2. Phase I and pharmacokinetic study of E7070, a novel sulphonamide, given daily × 5 every three weeks as a one-hour infusion in patients with advanced solid tumors;Punt;Proc Am Assoc Cancer Res,2000
3. Phase I and pharmacokinetic study of E7070, a new chloro-indolylsulfonamide, given as a one-hour infusion every three weeks in patients with advanced solid tumors;Raymond;Proc Am Assoc Cancer Res,2000
4. Phase I and pharmucokinetic study of E7070 in patients with solid tumors as single IV infusion, weekly × 4, Q six weeks;Dittrich;Proc Am Assoc Cancer Res,2000
5. Phase I Inal of five-days continuous infusion E7070 [N(3-chloro 7 indolyl)-l,4 benzene-disulfonamide] in patients with solid tumors;Droz;Proc Am Assoc Cancer Res,2000